Showing results (491-500 of 1,068) with videos related to
Sort By:
Pageof 107
Journal of Pharmacokinetics and Pharmacodynamics|October 22, 2025
Pharmacometric modeling with the zero-order holdEric L Haseltine, Violeta Rodriguez-RomeroJournal of Pharmacokinetics and Pharmacodynamics|July 23, 2025
Identification of oncology pharmacokinetic drivers through in vitro experiments and computational modelingBritton Boras, Eric C Greenwald, Yuli Wang, et al.Journal of Pharmacokinetics and Pharmacodynamics|July 14, 2025
Using Fisher Information Matrix to predict uncertainty in covariate effects and power to detect their relevance in Non-Linear Mixed Effect Models in pharmacometricsLucie Fayette, Karl Brendel, France MentréJournal of Pharmacokinetics and Pharmacodynamics|June 16, 2025
The dawn of a new era: can machine learning and large language models reshape QSP modeling?Ioannis P Androulakis, Lourdes Cucurull-Sanchez, Anna Kondic, et al.Journal of Pharmacokinetics and Pharmacodynamics|June 4, 2025
Leveraging large language models in pharmacometrics: evaluation of NONMEM output interpretation and simulation capabilitiesHwa Jun Cha, Kyuyeon Choe, Euibeom Shin, et al.Journal of Pharmacokinetics and Pharmacodynamics|February 24, 2024
A minimal physiologically based pharmacokinetic model to study the combined effect of antibody size, charge, and binding affinity to FcRn/antigen on antibody pharmacokineticsKrutika Patidar, Nikhil Pillai, Saroj Dhakal, et al.Journal of Pharmacokinetics and Pharmacodynamics|February 24, 2024
Subgroup identification-based model selection to improve the predictive performance of individualized dosingHiie Soeorg, Riste Kalamees, Irja Lutsar, et al.Journal of Pharmacokinetics and Pharmacodynamics|February 9, 2024
Population pharmacokinetics of the dual endothelin receptor antagonist aprocitentan in subjects with or without essential or resistant hypertensionJanneke M Brussee, Patricia N Sidharta, Jasper Dingemanse, et al.Journal of Pharmacokinetics and Pharmacodynamics|March 29, 2024
Longitudinal modeling of efficacy response in patients with lupus nephritis receiving belimumabMonica Simeoni, Shuying Yang, Debra J Tompson, et al.Journal of Pharmacokinetics and Pharmacodynamics|February 3, 2024
A population pharmacokinetics model of balovaptan to support dose selection in adult and pediatric populationsFranziska Schaedeli Stark, Clarisse Chavanne, Michael Derks, et al.Pageof 107